Proxy backlash: City anger at firms trying to limit exec payouts April 9, 2024 So-called proxy advisers are facing mounting anger in the City after urging shareholders to reject the paypackets of executives at two FTSE 100 firms.
European Green Transition hits London Stock Exchange on rare metal hopes April 8, 2024 The self-described ‘green economy asset developer carries a market capitalisation of £14.5m.
London Stock Exchange owner faces potential shareholder revolt over plans to double chief’s pay April 7, 2024 The owner of the London Stock Exchange is facing potential shareholder dissent after a key proxy advisor opposed plans to double its chief's pay amid a debate over how the Square Mile can compete with US-style remuneration deals.
Is the London Stock Exchange’s golden age of mining over? April 6, 2024 Glencore and Anglo American come immediately to mind when one considers the recent struggles for London miners.
DS Smith suitor pledges London Stock Exchange listing and headquarters in the City April 4, 2024 The US paper firm vying to snap up box-maker DS Smith has said it will look for a secondary listing in London and retain a base in the City if it is successful in buying the firm.
What this pension fund’s investments say about the London Stock Exchange April 3, 2024 A London pension fund has defended the way it invests its cash today after a new report shone a light on the wider dearth of retirement cash flowing onto the London Stock Exchange.
London loses another listed company as pharma riser goes private April 2, 2024 Shareholders will vote on the decision on 19 April, requiring 75 per cent to vote in favour of the move, it confirmed in a statement to markets this morning.
Keysight outbids Viavi in £1.15bn takeover of Spirent Communications March 28, 2024 An American company has invaded a £1bn agreed takeover deal Spirent Communications, in a shock move which will see another firm taken off the London market.
‘Unnecessarily costly and regulatorily burdensome’: AIM slammed as another firm quits March 28, 2024 A second listed business has announced plans to quit the London Stock Exchange's AIM in as many days.
Another listed company plans to quit London’s AIM market – this is why March 27, 2024 Drug company C4X Discovery has announced plans to quit the London Stock Exchange's AIM.